Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Hypothyroidism slows metabolism, causing growth and mental issues in children and reversible symptoms in adults, needing early treatment.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Alopecia is a key indicator of thallium poisoning.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

A 9-year-old girl developed type 1 diabetes and alopecia after being treated for a rare kidney disease.

The patient's hypothyroidism improved with medication adjustments and careful management.

Dietary linoleic acid may help reduce hyperthyroidism effects.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Excessive iodine from a cystic fibrosis supplement can cause hypothyroidism.

Ayurvedic treatment improved symptoms and reduced TSH levels in a hypothyroidism patient.

Itching can be an early sign of hyperthyroidism.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Alopecia areata involves unique activation of certain immune cells.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

Baricitinib works better than methotrexate for severe alopecia areata.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.